Legend Biotech Corporation - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US52490G1022

SecurityLEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
InstitutionMacquarie Group Ltd
Latest Disclosed Ownership6,096 shares
Latest Disclosed Value $ 110,277
Macquarie Group Ltd ownership in LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)

On May 15, 2026 - Macquarie Group Ltd filed a 13F-HR form disclosing ownership of 6,096 shares of Legend Biotech Corporation - Depositary Receipt (Common Stock) (US:LEGN) valued at $110,277 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 6,096 shares of Legend Biotech Corporation - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $198,852 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 6,096 0 0.00 110 -16.67 0.0005
2026-02-13 2025-12-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 6,096 2,267 59.21 133 6.45 0.0006
2025-11-13 2025-09-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 3,829 1,821 90.69 125 77.14 0.0001
2025-08-14 2025-06-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 2,008 -3,341 -62.46 71 -61.33 0.0001
2025-08-14 2025-03-31 13F/A-1 LEGEND BIOTECH SPONSORED ADS 52490G102 5,349 -1,538 -22.33 181 -18.83 0.0002
2025-05-15 2025-03-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 5,349 -1,538 181 0.0002
2025-02-14 2024-12-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 6,887 0 0.00 224 -33.43 0.0003
2024-11-14 2024-09-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 6,887 0 0.00 335 9.84 0.0004
2024-08-09 2024-06-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 6,887 0 0.00 305 -20.98 0.0003
2024-05-14 2024-03-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 6,887 0 0.00 387 -6.76 0.0004
2024-02-14 2023-12-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 6,887 1,283 22.89 414 10.11 0.0005
2023-11-14 2023-09-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 5,604 712 14.55 377 11.24 0.0005
2023-10-27 2023-06-30 13F/A-2 LEGEND BIOTECH SPONSORED ADS 52490G102 4,892 0 0.00 338 43.83 0.0004
2023-10-12 2023-06-30 13F/A-1 LEGEND BIOTECH SPONSORED ADS 52490G102 4,892 0 338 0.0003
2023-08-14 2023-06-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 4,892 0 338 0.0003
2023-06-01 2023-03-31 13F/A-1 LEGEND BIOTECH SPONSORED ADS 52490G102 4,892 1,941 65.77 236 60.96 0.0003
2023-05-15 2023-03-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 4,892 1,941 236 0.0002
2023-02-21 2022-12-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 2,951 0 0.00 147 20.66 0.0002
2022-11-14 2022-09-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 2,951 1,298 78.52 121 32.97 0.0001
2022-08-17 2022-06-30 13F/A-1 LEGEND BIOTECH SPONSORED ADS 52490G102 1,653 -1,052 -38.89 91 -7.14 0.0001
2022-08-15 2022-06-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 1,653 -1,052 91 0.0000
2022-05-16 2022-03-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 2,705 0 0.00 98 -22.22 0.0001
2022-02-11 2021-12-31 13F Legend Biotech SPONSORED ADS 52490G102 2,705 2,638 3,937.31 126 4,100.00 0.0001
2021-11-12 2021-09-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 67 0 0.00 3 0.00 0.0000
2021-08-13 2021-06-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 67 0 0.00 3 50.00 0.0000
2021-05-14 2021-03-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 67 0 0.00 2 0.00 0.0000
2021-02-16 2020-12-31 13F LEGEND BIOTECH SPONSORED ADS 52490G102 67 1 1.52 2 0.00 0.0000
2020-11-13 2020-09-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 66 -799 -92.37 2 -94.59 0.0000
2020-08-11 2020-06-30 13F LEGEND BIOTECH SPONSORED ADS 52490G102 865 865 37 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.